Research
Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials
Lisa Rambout, Laura Hopkins, Brian Hutton and Dean Fergusson
CMAJ August 28, 2007 177 (5) 469-479; DOI: https://doi.org/10.1503/cmaj.070948
Lisa Rambout BScPhm
Laura Hopkins MD MSc
Brian Hutton MSc
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials
Lisa Rambout, Laura Hopkins, Brian Hutton, Dean Fergusson
CMAJ Aug 2007, 177 (5) 469-479; DOI: 10.1503/cmaj.070948
Jump to section
Related Articles
Cited By...
- Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
- Cervical Cancer, Version 2.2015
- Cervical Cancer
- Cervicovaginal Self-Sampling Is a Reliable Method for Determination of Prevalence of Human Papillomavirus Genotypes in Women Aged 20 to 30 Years
- Evidence-based clinical guidelines for immigrants and refugees
- Cervical Cancer
- Human papillomavirus (HPV) vaccination and the development of public policies
- Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study
- Vaccination against human papillomavirus
- Vaccination against human papillomavirus
- Human papillomavirus, vaccines and women's health: questions and cautions